Ladenburg Thalmann Financial Services’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $84K | Sell |
937
-77
| -8% | -$6.9K | ﹤0.01% | 3154 |
|
|
2019
Q3 | $81K | Buy |
1,014
+342
| +51% | +$27.3K | ﹤0.01% | 3095 |
|
|
2019
Q2 | $52K | Sell |
672
-353
| -34% | -$27.3K | ﹤0.01% | 3439 |
|
|
2019
Q1 | $121K | Buy |
1,025
+182
| +22% | +$21.5K | ﹤0.01% | 2765 |
|
|
2018
Q4 | $91K | Buy |
843
+748
| +787% | +$80.7K | ﹤0.01% | 2815 |
|
|
2018
Q3 | $12K | Sell |
95
-565
| -86% | -$71.4K | ﹤0.01% | 4198 |
|
|
2018
Q2 | $74K | Hold |
660
| – | – | ﹤0.01% | 2980 |
|
|
2018
Q1 | $74K | Buy |
660
+18
| +3% | +$2.02K | ﹤0.01% | 2980 |
|
|
2017
Q4 | $96K | Buy |
642
+59
| +10% | +$8.82K | ﹤0.01% | 2760 |
|
|
2017
Q3 | $68K | Sell |
583
-42
| -7% | -$4.9K | ﹤0.01% | 2872 |
|
|
2017
Q2 | $81K | Sell |
625
-79
| -11% | -$10.2K | ﹤0.01% | 2652 |
|
|
2017
Q1 | $96K | Sell |
704
-13
| -2% | -$1.77K | ﹤0.01% | 2430 |
|
|
2016
Q4 | $104K | Buy |
717
+73
| +11% | +$10.6K | ﹤0.01% | 2296 |
|
|
2016
Q3 | $77K | Sell |
644
-114
| -15% | -$13.6K | ﹤0.01% | 2438 |
|
|
2016
Q2 | $81K | Sell |
758
-184
| -20% | -$19.7K | ﹤0.01% | 2307 |
|
|
2016
Q1 | $105K | Sell |
942
-264
| -22% | -$29.4K | ﹤0.01% | 2024 |
|
|
2015
Q4 | $188K | Buy |
1,206
+73
| +6% | +$11.4K | ﹤0.01% | 1626 |
|
|
2015
Q3 | $148K | Sell |
1,133
-132
| -10% | -$17.2K | ﹤0.01% | 1712 |
|
|
2015
Q2 | $219K | Buy |
1,265
+25
| +2% | +$4.33K | ﹤0.01% | 1552 |
|
|
2015
Q1 | $215K | Buy |
1,240
+395
| +47% | +$68.5K | ﹤0.01% | 1524 |
|
|
2014
Q4 | $112K | Sell |
845
-206
| -20% | -$27.3K | ﹤0.01% | 1820 |
|
|
2014
Q3 | $135K | Sell |
1,051
-209
| -17% | -$26.8K | ﹤0.01% | 1437 |
|
|
2014
Q2 | $111K | Sell |
1,260
-516
| -29% | -$45.5K | ﹤0.01% | 1540 |
|
|
2014
Q1 | $167K | Buy |
1,776
+29
| +2% | +$2.73K | ﹤0.01% | 1218 |
|
|
2013
Q4 | $197K | Sell |
1,747
-136
| -7% | -$15.3K | 0.01% | 1085 |
|
|
2013
Q3 | $153K | Buy |
1,883
+930
| +98% | +$75.6K | 0.01% | 1145 |
|
|
2013
Q2 | $63K | Buy |
+953
| New | +$63K | ﹤0.01% | 1571 |
|